AK MEDICAL (01789) announced on September 17, 2026, that it spent HK$242,000 to repurchase 50,000 of its own shares.
This buyback reflects the company's ongoing capital management strategy, with the transaction conducted on the open market as disclosed in its latest filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.